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Abstract
Colorectal cancer (CRC) is a major public health problem, and its incidence is rising in developing countries. However, studies
characterizing CRC clinicopathological features in cases from developing countries are still lacking. The goal of this study was to
evaluate clinicopathological and demographic features in one of the largest CRC studies in Latin America.
The study involved over 1525 CRC cases recruited in a multicenter study in Colombia between 2005 and 2014 as part of ongoing
genetic and epidemiological studies. We gathered clinicopathological data such as age at diagnosis, sex, body mass index, tobacco
and alcohol consumption, family history of cancer, and tumor features including location, histological type, and stage. Statistical
analyses were performed to test the association between age of onset, sex, and clinical manifestations.
The average age at CRC diagnosis was 57.4 years, with 26.5% of cases having early-onset CRC (diagnosed by age 50 years).
Most cases were women (53.2%; P=0.009), 49.2% were overweight or obese, 49.1% were regular alcohol drinkers, 52% were
smokers/former smokers, and 12.2% reported relatives with cancer. Most tumors in the study were located in the rectum (42.7%),
were adenocarcinomas (91.5%), and had advanced stage (T3–T4, 79.8%). Comparisons by sex found that male cases were more
likely to be obese (36.5% vs 31.1%; P=0.001), less likely to have a family history of cancer (9.7% vs 15.3%; P=0.016), and more
likely to have advanced-stage tumors (83.9% vs 76.1%; P=0.036). Comparisons by age of onset found that early-onset cases were
more likely to be women (59.3% vs 51.0%; P=0.005) and report a family history of cancer (17.4% vs 10.2%; P=0.001).
To our knowledge, our study is the largest report of clinicopathological characterization of Hispanic CRC cases, and we suggest
that further studies are needed to understand CRC etiology in diverse Hispanic populations.
Abbreviations: ASR = age-standardized rates, BMI = body mass index, CRC = colorectal cancer, TNM = tumor, lymph node,
metastasis.
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Colorectal cancer (CRC) is a global public health concern, with
an increasing incidence and mortality rates in the developing
countries.[1] Various estimates indicate that CRC incidence isEditor: Somchai Amornyotin.
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1increasing in countries with limited healthcare resources,
particularly in Latin America and Eastern Europe.[2] Worldwide,
CRC is the third leading cause of cancer mortality in men and the
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Table 1
Demographic and risk factor data in 1525 Colombian colorectal
cancer cases.
Feature
∗
Description No. of cases (%)
Sex Male 714 (46.8)
Female 811 (53.2)
Age of onset Early (50 y) 405 (26.6)
Late (>50 y) 1120 (73.4)
BMI Normal 396 (50.8)
Overweight 122 (15.6)
Obese 262 (33.6)
Alcohol† Drinker 645 (50.9)
Nondrinker 619 (49.1)
Smoking‡ Smoker/former smoker 558 (48.0)
No smoker 604 (52.0)
Family history of cancerx Absent 1123 (87.8)
Present 155 (12.2)
∗
Full data on BMI at diagnosis, alcohol, smoking, and family history was available for 780, 1264,
1162, and 1278 cases, respectively.
† Patient was classiﬁed as a drinker if he/she consumed >5 alcohol units/wk for >1 year.
‡ Patient was classiﬁed as a smoker if he/she smoked >10cigarettes/wk for >5 years.
x Family history of cancer was deﬁned as the presence of cancer in the ﬁrst or second-degree relatives.
Bohorquez et al. Medicine (2016) 95:40 Medicineby sex, age, and race. For example, CRC is more commonly
diagnosed in older individuals and in men in most of the
developed countries, its incidence is higher in African Americans,
and higher CRC mortality is often associated with lower
socioeconomic status.[4–6] Environmental exposures, and per-
sonal and family history of colorectal polyps[7–11] and cancer[12]
are both known risk factors for CRC development. CRC
outcomes depend primarily on the distribution and spread of the
disease, and also early diagnosis and intervention.[13]
In Colombia, an upper-middle income country with the third
largest population in Latin America, CRC is the fourth most
common cause of cancer incidence and mortality with age-
standardized rates (ASRs) for incidence 13.4 and 12.5 per
100,000 among men and women, respectively, and mortality
ASR 7.6 and 7.0 per 100,000 for men and women, respective-
ly.[14] These rates reﬂect a signiﬁcant increase in the CRC
incidence in Colombia when compared with previous years.[15]
Furthermore, mortality trends in this country show a signiﬁcant
increase for both sexes.[16] Despite the associated burden, scarce
data are available on clinical characteristics of CRC in Colombia
andHispanic populations, which have unique admixed American
Indian, African, and European origin.[17–20] Therefore, the goal
of this multicenter study was to describe the clinicopathological
characteristics of a large cohort of Colombian CRC cases.[21–23]
The data gathered in our study, which, to our knowledge, are the
largest in Hispanics from Latin America or the United States, will
be useful to support future research and to inform prevention and
screening programs in these populations.2. Materials and methods
2.1. Study population
A total of 1525 CRC-incident cases diagnosed between 2006 and
2014 were enrolled as part of ongoing CRC genetic studies
in Colombia.[21–23] Cases were recruited through large cancer
hospitals in 10 of largest Colombian cities (Cartagena, Santa
Marta, Barranquilla, Cali, Pasto, Medellin, Bucaramanga,
Bogota, Ibague, Neiva), and hence the study population is
representative of most major geographical regions in the country
and where most of Colombians are settled. The study adhered to
the Helsinki Declaration and received IRB approvals from
University of Tolima and Instituto Nacional de Cancerologia
(Colombian National Cancer Institute), and also from ethic
committees at the clinical centers when required (University of
Tolima, Hospital Federico Lleras Acosta, Hospital Hernando
Moncaleano Perdomo, Hospital Pablo Tobon Uribe, and
multiple private oncology centers).2.2. Demographic and clinical data
After providing informed consent, patients were interviewed in
person by trained research nurses. A questionnaire was
completed and information was collected about sociodemo-
graphic characteristics, height, weight, smoking and drinking
habits, and family history of cancer. Using the questionnaire and
histopathology reports, we obtained information about sex, age
at diagnosis (in years), family history of cancer in ﬁrst and
second-degree relatives, histological subtype, degree of differen-
tiation, tumor location (see below), presence of synchronous or
metachronous colorectal and extracolorectal tumors, type of
resection (right, left, rectum), number of positive lymph nodes,
and the tumor, lymph node, metastasis (TNM) stage. The2histopathological re-classiﬁcation was performed according to
the latest recommendations of the World Health Organiza-
tion.[24] Tumor location was determined as proximal (cecum,
appendix, ascending colon, hepatic ﬂexure, and transverse
colon), distal (splenic ﬂexure, descending colon, and sigmoid
colon), or rectal.2.3. Statistical analyses
We stratiﬁed patients by age of diagnosis or by sex. Those with
CRC by age of 50 years were classiﬁed as early-onset cases and
those diagnosed with CRC >50 years were classiﬁed as having
late-onset disease. Chi-square tests were used to explore
associations between age of onset or sex and clinical variables.
For cases with histopathology reports from surgical resections
(n=543 cases), we also explored associations between age of
onset, and sex and histological variables such as tumor stage,
presence or absence of lymph node metastasis, and TNM. Data
were analyzed using the R software.[25]3. Results
3.1. Demographic and clinical features of the study cohort
Table 1 shows the main clinical and histological characteristics of
the 1525 CRC cases analyzed in our study. We found a
signiﬁcantly higher number of female cases than that of male
cases in our study (811 female cases and 714 male cases; P=
0.009; Table 1). The average age at CRC diagnosis in the cohort
was 57.4 years (range 19–75 years), with men and women having
similar average age at diagnosis (57 and 58 years, respectively;
data not shown). Four hundred ﬁve cases had early-onset disease
and 1120were late-onset cases. Of the late-onset cases, 37%were
diagnosed between ages 51 and 60 years, and 63% >60 years
(data not shown). At the time of diagnosis, 50.8% of these cases
had normal body mass index (BMI, range 20–25), whereas
15.6% were overweight and 33.6% were obese. Analysis of
alcohol consumption indicated that 51% regularly consumed
alcohol and 49% were nondrinkers. Similarly, analysis of
smoking habits indicated that 48% of these cases were
Table 3
Clinical and demographic characteristics stratiﬁed by the sex of
the case.
Number of cases (%)
Feature Male Female 2-sided P
Age of onset
Early 166 (23.1) 240 (29.5)
Late 549 (76.9) 570 (70.5) 0.0056
BMI
Normal 167 (46.1) 229 (54.8)
Overweight 63 (17.40) 59 (14.1)
Obese 132 (36.5) 130 (31.1) 0.001
Alcohol
Drinker 304 (49.8) 341 (52.1)
Nondrinker 307 (50.2) 312 (47.9) 0.412
Smoking
Smoker/former smoker 265 (47.1) 293 (48.9)
Nonsmoker 297 (52.9) 307 (51.1) 0.607
Family history of cancer
Absent 540 (90.3) 583 (84.7)
Present 58 (9.7) 97 (15.3) 0.016
Tumor location
Proximal 128 (28.9) 126 (25.8)
Distal 121 (27.3) 159 (32.6)
Rectal 194 (43.8) 203 (41.6) 0.200
Histological subtype
Adenocarcinoma 551 (92.1) 619 (91.0)
Mucinous carcinoma 32 (5.4) 35 (5.2)
Signet ring cell carcinoma 11 (1.8) 9 (1.3)
Other 4 (0.7) 17 (2.5) 0.069
T stage
Table 2
Clinical and histological characteristics of the Colombian cases
included in the study.
Feature Description No. of cases (%)
Tumor location† Proximal 254 (27.3)
Distal 279 (30.0)
Rectal 398 (42.7)
Histological subtype Adenocarcinoma (NOS) 1170 (91.5)
Mucinous carcinoma 67 (5.2)
Signet ring cell carcinoma 20 (1.6)
Other 21 (1.7)
T stage
∗
T0–T2 103 (20.2)
T3–T4 408 (79.8)
Lymph node metastasis
∗
Absent 311 (63.7)
Present 177 (36.3)
pTNM stage
∗
Early (0, I, II) 290 (59.4)
Advanced (III, IV) 198 (40.6)
∗
Data on tumor stage, lymph node, and metastasis (TNM) were derived from the cases for which we
had access to pathology reports from surgical specimens. Full data on these variables were readily
available in 511, 488, and 488 cases, respectively.
† Full data on tumor location was readily available in 931 cases.
Bohorquez et al. Medicine (2016) 95:40 www.md-journal.comsmokers/former smokers, whereas 52%were nonsmokers. Of all
cases, 87.8%did not report relatives with cancer, whereas 12.2%
reported ﬁrst-degree relatives with cancer. Out of 155 patients
with cancer family history, 55 cases fulﬁlled the criteria for Lynch
syndrome and 7 cases fulﬁlled the criteria for familial adenoma-
tous polyposis[26] (data not shown).T0–T2 39 (16.1) 64 (23.9)
T3–T4 204 (83.9) 204 (76.1) 0.036
Lymph nodes metastasis
Absent 149 (63.4) 162 (64.0)
Present 86 (36.6) 91 (36.0) 0.960
TNM
Early (0, I, II) 81 (27.9) 68 (34.3)
Advanced (III, IV) 209 (72.1) 130 (65.7) 0.159
BMI=body mass index, TNM= tumor, lymph node, metastasis.3.2. Histological features and TNM staging
Out of all cases, information about tumor location was readily
available in 931 cases and information about tumor stage in 511
cases. For 735 cases, the source of histopathological information
(histopathology reports) was biopsies, whereas for 543 cases
reports were available from surgical resections. Therefore, we
were able to analyze TNM staging only in a subset of 488 patients
with complete histopathological reports from surgical specimens.
Table 2 summarizes the main clinical and histological character-
istics of the tumors belonging to the participant cases in our
study. Tumors in our Colombian cases occurred more frequently
in the rectum (42.7% of the cases had rectal tumors compared
with 30% with distal and 27.3% with tumors at the proximal
location). The most common tumor type was the adenocarcino-
ma, diagnosed in 91.5% of the cases, followed by mucinous
carcinoma in 5.2% cases and carcinoma with signet ring cells
histology in 1.6% of cases. Other histological subtypes included
squamous cell carcinoma and neuroendocrine tumors, which
accounted for 1.7% of the cases (data not shown). We also found
that 79.8% of the cases had advanced stages and 20.2% had
early-stage tumors. The analysis of the lymph node metastasis,
however, indicated that 63.7% reported no lymph node
involvement, whereas 36.3% included involvement of 1 or more
nodes. We found an average of 10.7 lymph nodes were examined
per case (data not shown), in contrast to recommended
examination of a minimum of 12 lymph nodes. However, for
advanced rectal cancer, the number of cases with lymph nodes
examined in this cohort was 42.7% and such cases were mostly
treated with preoperative radiotherapy. We acknowledge that
this approach can diminish the amount of lymph nodes dissected
at the surgical specimen, and lymph node clearance was not done
as a rule in the surgical specimen study. Table 2 also shows that,3based on TNM classiﬁcation, advanced tumors were diagnosed
in more than 40% of all cases.3.3. Differences in clinical manifestations by the sex and
age of onset
Intrigued by a higher proportion of female cases in our study, we
decided to analyze the clinicopathological characteristics, strati-
ﬁed by sex. Table 3 shows the results of these comparisons. We
found that female cases, when compared with male cases, were
more likely to be diagnosed with early-onset CRC (30% vs 23%;
P=0.005), to have a normal weight at time of CRC diagnosis
(55% vs 46%; P=0.001), to report a family history of cancer
(15% vs 10%; P=0.016), and to be diagnosed with localized
tumors (24% vs 16%; P=0.036). Table 4 shows the results when
analyses were stratiﬁed by age of onset (early onset vs late onset).
As expected, most early-onset cases were women, who
represented 59% of these cases. Early-onset cases, compared
with older cases, reported more often family history of cancer
(17% vs 10%; P=0.001), had more rectal tumors (49% vs 40%;
P=0.012), were less likely to be diagnosed with proximal tumors
(21% vs 30%), and had a higher fraction of mucinous or signet
ring cell tumors (14% vs 5%; P<0.001).
Table 4
Clinical and demographic characteristics, stratiﬁed by the age of
onset of the case.
Number of cases (%)
Early onset Late onset P
Sex
Male 165 (40.7) 549 (49.0)
Female 240 (59.3) 571 (51.0) 0.005
Alcohol
Drinker 163 (49.1) 482 (51.7)
Nondrinker 169 (50.9) 450 (48.3) 0.450
Smoking
Smoker/former smoker 152 (47.0) 406 (48.4)
No smoker 171 (53.0) 433 (51.6) 0.733
Weight
Normal 101 (53.2) 295 (50.0)
Overweight 32 (16.8) 90 (15.3)
Obese 57 (30.0) 205 (34.7) 0.478
Family history of cancer
Absent 280 (82.6) 843 (89.8)
Present 59 (17.4) 96 (10.2) 0.001
Tumor location
Proximal 57 (21.1) 197 (29.8)
Distal 81 (30.0) 199 (30.1)
Rectal 132 (48.9) 265 (40.1) 0.012
Histological subtype
Adenocarcinoma 289 (85.3) 881 (93.8)
Mucinous carcinoma 33 (9.7) 34 (3.6)
Signet ring cell carcinoma 12 (3.5) 8 (0.9)
Other 5 (1.5) 16 (1.7) 0.000
Tumor stage
T0–T2 24 (16.1) 79 (21.8)
T3–T4 125 (83.9) 283 (78.2) 0.179
Lymph nodes metastasis
Absent 86 (61.4) 225 (64.7)
Present 54 (38.6) 123 (35.3) 0.571
TNM
Early (0, I, II) 81 (54.4) 209 (51.3)
Advanced (III, IV) 68 (45.6) 198 (48.7) 0.413
TNM= tumor, lymph node, metastasis.
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In this study, we carried out a comprehensive evaluation of the
clinicopathological features in, what is, to our knowledge, the
largest existing cohort of Hispanic CRC cases. The study was
conducted by sampling more than 1500 incident cases from
several Colombian regions, in which we collected and analyzed
several demographic, clinical, and pathological variables. Our
study uncovered important key features of Colombian CRC cases
such as a signiﬁcant proportion of individuals (26.5%) had early-
onset disease and a large fraction of cases were female, had rectal
tumors, and advance disease.
One of the most striking ﬁnding of the study was the presence
of a higher fraction female CRC cases (53.2% women vs 46.8%
men). This is in contrast to reports from developed countries,
including reports on US Hispanics, where men are more often
diagnosed with CRC.[3,14,27–29] Our ﬁndings are, however,
consistent with previous reports suggesting a higher CRC
incidence in Colombian women.[5,14] Interestingly, when we
carried sex-stratiﬁed analysis, we found that compared with men,
a statistically signiﬁcant higher proportion of female cases had
normal BMI at CRC diagnosis (55% vs 46%), diagnosed at
younger age (30% female cases had early-onset CRC, compared4with 23% males), and reported higher family history of cancer
(15% vs 10%). Our ﬁndings of a higher proportion of female
CRC cases having normal BMI are consistent with previous
studies that failed to detect consistent association between obesity
and CRC cases in females, in contrast to males.[30] Various
genetic and environmental factors such as diet, hormonal
exposure, reproductive history, and willingness to seek medical
help may contribute to these sex-related disparities. However,
case-control and cohort studies are clearly needed to understand
these sex differences in Hispanic CRC cases from Latin
America.[31,32]
Our Colombian cases were also unique in terms of age at CRC
onset. The average age of CRC diagnosis in our cohort was 57.4
years, with 26.5% of cases diagnosed with early-onset disease.
These ﬁndings are in contrast to cases from the developed
countries where the average age at CRC diagnosis ranges from 64
to 72 years.[33] However, our ﬁndings echo the recent evidence
that suggests rise in early-onset CRC cases, speciﬁcally in US
minorities like Hispanics.[34,35] Interestingly, early-onset cases in
our study reported a family history of cancer more often than
older cases (17% vs 10%), indicating a possible role of a genetic
predisposition. Indeed, we have carried small-scale genetic
studies in some of these individuals and have identiﬁed carriers
of mutations in highly penetrant genes.[21,23] Early-onset cases
were also enriched for tumors of mucinous and signet ring
subtypes (14% vs 5%), tumor types that are known to be more
aggressive and have poor prognosis.[36–38] A higher fraction of
early-onset cases in Colombia could partly reﬂect the demogra-
phy of the country, which has a larger fraction of younger
individuals than countries in the developed world.[39] Nonethe-
less, other factors such as environment, heredity, lifestyle, and
ancestry, which could play a role in early-onset disease, need to be
further studied in this population.[40] Our ﬁndings of a high
fraction of early-onset cases and their aggressive tumor types
strongly support the need to modify screening strategies to
include younger Colombian individuals.[35,41] Additionally,
molecular testing to screen for mutations in CRC predisposition
genes could also beneﬁt better understanding of the etiology and
management of early-onset cases.
A third interesting ﬁnding of our study was the large fraction of
cases with rectal tumors (42.7%). Similar to previous studies,
early-onset cases were more commonly diagnosed with rectal
tumors (49%).[34,42] Patients with distal and rectal CRC, in
addition to presenting symptoms earlier and differences in
prognosis, show different embryological origin, digestive func-
tion, and gene expression, when compared with those tumors at
other locations.[43,44] As the cases in this study were not identiﬁed
as a result of screening, it is likely that the high proportion of
rectal and distal cases could be explained by the presence of
symptoms such as bleeding and changes in bowel habits, which
cause patients to consult a physician earlier.[45] The majority of
our cases also had advanced stages of tumor (T3–T4, 79.8%) that
could explain the high rate of mortality in countries with limited
resources like Colombia.[46,47]
We also acknowledge the limitations of the study, including the
fact that full data collection was not possible due to incomplete
clinical records in the hospitals from this limited-resource
country. Furthermore, even though all patients were in person
interviewed by trained nurses, an important fraction of such
interviews occurred during hospital visits when the patients could
not readily provide accurate information due to time limitations
for the interview or poor/difﬁcult state of the patient. We also
acknowledge that future studies should carry out a population-
Pages/fact_sheets_population.aspx. Published 2012. Accessed January
Bohorquez et al. Medicine (2016) 95:40 www.md-journal.combased approach, but given the limited number of cancer registries
existing in the county, such studies are likely to be very difﬁcult.
Because our study was carried out in large cancer hospitals from
the main cities, we are conﬁdent that it reﬂects the most common
characteristics of CRC cases in Colombia. Furthermore, because
medicine in Colombia is socialized, we are conﬁdent our results
are representative of the main clinical characteristics of CRC
cases from the entire Colombian population. Despite some of
these limitations, we believe that our large study uncovered many
interesting and unique clinicopathological characteristics of
Colombian CRC patients that are worth following up in future
clinical and epidemiological studies.
In summary, our ﬁndings, in a large sample of Hispanic
patients from a multicenter study, highlight some of the key
clinicopathological features of CRC cases from a developing
country such as Colombia that will be helpful in further
understanding the causation and designing better strategies for
CRC diagnosis and management. More extensive epidemiologi-
cal and molecular studies are needed to allow a better
understanding of CRC etiology in this Hispanic population.Acknowledgments
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